CN1109882A - 新型3-氧代-1，4-苯并噻嗪衍生物 - Google Patents

新型3-氧代-1，4-苯并噻嗪衍生物 Download PDF

Info

Publication number
CN1109882A
CN1109882A CN94112918A CN94112918A CN1109882A CN 1109882 A CN1109882 A CN 1109882A CN 94112918 A CN94112918 A CN 94112918A CN 94112918 A CN94112918 A CN 94112918A CN 1109882 A CN1109882 A CN 1109882A
Authority
CN
China
Prior art keywords
hydroxyl
compound
alkyl group
low alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94112918A
Other languages
English (en)
Chinese (zh)
Inventor
河洋一
太田淳稔
森川裕子
壬生宽之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of CN1109882A publication Critical patent/CN1109882A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6544—Six-membered rings
    • C07F9/6547—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN94112918A 1993-12-09 1994-12-08 新型3-氧代-1，4-苯并噻嗪衍生物 Pending CN1109882A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP309131/93 1993-12-09
JP30913193 1993-12-09

Publications (1)

Publication Number Publication Date
CN1109882A true CN1109882A (zh) 1995-10-11

Family

ID=17989274

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94112918A Pending CN1109882A (zh) 1993-12-09 1994-12-08 新型3-氧代-1，4-苯并噻嗪衍生物

Country Status (10)

Country Link
US (1) US5547952A (enExample)
EP (1) EP0657444B1 (enExample)
KR (1) KR950017982A (enExample)
CN (1) CN1109882A (enExample)
AT (1) ATE178323T1 (enExample)
CA (1) CA2137626A1 (enExample)
DE (1) DE69417523T2 (enExample)
FI (1) FI945762A7 (enExample)
NO (1) NO944762L (enExample)
TW (1) TW306919B (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923709A (en) * 1974-08-30 1975-12-02 Monsanto Co 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
US4078062A (en) * 1976-10-28 1978-03-07 E. R. Squibb & Sons, Inc. Substituted 2H-1,4-benzothiazin-3(4H)-ones
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
GB8413915D0 (en) * 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
JPH0730058B2 (ja) * 1988-05-14 1995-04-05 参天製薬株式会社 ３−オキソ−１，４−ベンゾチアジン誘導体
WO1994005647A1 (fr) * 1992-08-31 1994-03-17 Santen Pharmaceutical Co., Ltd. Derive de 3-oxo-1,4-benzothiazine

Also Published As

Publication number Publication date
ATE178323T1 (de) 1999-04-15
FI945762L (fi) 1995-06-10
CA2137626A1 (en) 1995-06-10
DE69417523D1 (de) 1999-05-06
FI945762A7 (fi) 1995-06-10
FI945762A0 (fi) 1994-12-08
TW306919B (enExample) 1997-06-01
EP0657444B1 (en) 1999-03-31
DE69417523T2 (de) 1999-09-16
EP0657444A1 (en) 1995-06-14
NO944762D0 (no) 1994-12-08
US5547952A (en) 1996-08-20
NO944762L (no) 1995-06-12
KR950017982A (ko) 1995-07-22

Similar Documents

Publication Publication Date Title
CN1131217C (zh) 苯基吡咯化合物和其制备方法及抗高血脂药
CN1023700C (zh) 芳族及杂环甲酰胺衍生物抗肿瘤剂的制备
CN1035508A (zh) 新的取代的喹啉衍生物的制备方法
CN1036393C (zh) 7-(2-氨乙基)-苯并噻唑酮
CN1271355A (zh) 杂环化合物和以其为有效成分的抗肿瘤剂
CN1031230A (zh) 具有类视网膜活性的苯基和杂二环基取代的乙炔及其制备方法
CN88101642A (zh) 哌嗪基-杂环化合物
CN87106163A (zh) 新颖的取代喹啉衍生物及其制备方法
CN1106811A (zh) 哌啶和哌嗪衍生物
CN1057464A (zh) 吡唑并嘧啶酮类抗心绞痛剂
CN85109554A (zh) 氨基水杨酸衍生物及其盐和其药用组合物的制备方法
CN1216982A (zh) 含氮三环化合物和含有该化合物的药物
CN1191248C (zh) 作为多巴胺d 受体亚型配体的1－(2－萘基)和1－(2－氮杂萘基)－4－(1－苯基甲基)哌嗪
CN1157375C (zh) 吲哚衍生物及其药物组合物
CN1050604C (zh) 具有抗精神病作用的化合物
CN1145627C (zh) 吡唑并[4,3-d]嘧啶类
CN87102891A (zh) 硫化内酰胺-n-乙酸衍生物的生产及使用
CN1304401A (zh) calcilytic化合物
CN1074904A (zh) 苯并呋喃基-和噻吩基甲硫基-链烷羧酸衍生物
CN1278809A (zh) 取代的苯并二氢吡喃衍生物
CN1035663A (zh) 取代的喹啉衍生物的制备方法
CN1025676C (zh) 非肽的血管紧张肽原酶抑制剂的制备
CN1058399A (zh) 作为胆固醇生物合成抑制剂的新型哌啶醚和硫醚
CN1125446A (zh) [1，2，4]三唑并[4，3-α]喹喔啉化合物，它们的制备及其应用
CN1208333C (zh) 主要用于治疗骨质疏松的吲哚衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication